Skip to main content
123 Results For "leishmaniasis"
 
msf-placeholder
DNDi

DNDi diseases focus

DNDi plans to spend around US$250 million over 12 years to develop 6-7 drugs and several drugs in the pipeline to combat sleeping sickness, leishmaniasis and Chagas disease - three killer diseases that threaten a combined 350 million people every year.

Read about these diseases below.
Project Update - 3 Jul 2003
 
msf-placeholder
DNDi

Raiding the medicine cabinet

Reinventing the economics of the drug industry presents a different challenge for MSF. Can MSF and its partners really succeed where the pharmaceutical giants, and their multi-billion-dollar budgets, have failed? Yes, claims Bernard Pecoul, who heads MSF's Access to Essential Medicines campaign. "It's an alternative model based on user needs and equitable access rather than profit," he says. Project Update - 3 Jul 2003
 
msf-placeholder
DNDi

DNDi launch: Best science for the most neglected

New not-for-profit drug research organisation born, DNDI will be the first not-for-profit organisation to exclusively focus on the world's most neglected diseases. Moving away from the traditional Public Private Partnership structure, it intends to take drug development out of the marketplace by encouraging the public sector to take more responsibility for health. Press Release - 3 Jul 2003
 
msf-placeholder
Kala azar

Drugs for neglected diseases

The Drugs for Neglected Diseases Initiative comes amid accusations that the west has ignored the plight of poor patients by either minimising funding or failing to do research on new drugs for diseases that affect them. Project Update - 1 Jul 2003
 
msf-placeholder
Neglected diseases

Evian G8 - MSF calls for promises to be kept

14 million people die each year from infectious and parasitic diseases. That is 19,000 people per day, or 6 people every 30 seconds. Can we accept this? The MSF teams will symbolise the urgency of the current situation through the spectacle "Suspended Life". Every 30 seconds an MSF volunteer will try to reach a giant pill from the top of a 6-metre structure. Unable to reach the pill, the volunteer falls into the void... This new MSF exhibit premieres at the G8 conference.

Médecins Sans Frontières will be present at the Evian G8 summit from May 30 to June 3.
Project Update - 30 May 2003
 
msf-placeholder
Access to medicines

The G8 : no more broken promises

The G8 have the financial and pharmaceutical resources to do an enormous amount of good. They should do this. In other words, the G8 should move towards meeting past commitments rather than away from them, and to demonstrate to the developing world that it can put global health above the interests of industry in the developed world. No more broken promises. Project Update - 10 May 2003
 
msf-placeholder
DNDi

New drug research body will tackle diseases that kill the poor

Drugs for Neglected Diseases Initiative (DNDi) links MSF with public health bodies from several countries in an attempt to bridge the gap between drug development and global illness. It includes research institutes in Brazil, France, India, Kenya and Malaysia. DNDi planned to spend about $US250million ($370million) over 12 years to develop six drugs and get several others in the pipeline, Ms Dinh said. Project Update - 7 May 2003
 
msf-placeholder
Somalia

Bare bone facts about Somalia - an MSF briefing document

MSF has been working in Somalia since 1986. We saw the terrible build up of slaughter and famine that eventually produced the American led and UN backed military intervention on November 9 1992. The civil war that erupted after the fall of the long-term dictatorship of Siad Barre smashed central authority and stimulated a multiplication of clan factions struggling for local power. Project Update - 9 Dec 2002
 
msf-placeholder
South Sudan

Health organisation warns that kala-azar has returned to South Sudan

Médecins Sans Frontières (MSF) has warned that a new outbreak of kala-azar, or visceral leishmaniasis, could wreak havoc among the population of southern Sudan, whose nutritional status is severely compromised by 20 years of war and famine. Project Update - 23 Nov 2002
 
msf-placeholder
Access to medicines

Access Campaign accomplishments 1999-2002

There has been a collection of high quality posters designed specifically for the Access Campaign in the MSF offices worldwide over the past three years. This collection shows some of the range for the posters. Project Update - 18 Nov 2002
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more